Skyline Hong Kong
Dicada | E + | Getti images
Regencell Bioscience HoldingsEarly-phase, Hong Kong-based biopacing company without income, is the latest speculative cash in order to attract an unusual increase in demand for trade.
The shares of Regencel, which says that traditional treatments of Chinese herbs for the treatment of attentionfulness and autism, more than 280% of approximately more than 280% approximately Split 38-ZA-1 Declared 2. June came into effect. By the end of Monday, Regencell, founded in 2014. year and traded under Ticker “RGC” from 2021. year, had a total market capitalization of $ 29.7 billion, according to S & P Capital IK.
Stocks still jumped on Tuesday, getting more than 25%. The year of production to current performance is also excluded in graphs, and increased by more than 58,000% in 2025. its current market value in the amount of 36 billion dollars Lululemon, eBay and Kraft Heinz. The actions are traded in one year for coins at one point.
Regencell Bioscience Holdings 2025.
Regencell is the latest example of speculative international inventory that attracts attention during summer trading. For example, 2022. August, for example, Amd DigitalFintech Company based on Hong Kong, climbed to 126%briefly give him market value more than Coca-Cola and Bank of America.
Earlier this month, Regencell explained that stocks were divided as designed only “to improve liquidity in the market for ordinary company shares and make the actions available to investors.” SPLITE ACTION Don’t change anything basically about the company.
Regencelov grew up and in the middle of increased focus on alternative medication after Robert F. Kennedy Jr. He swore as the secretary of the Ministry of Health and the Human Services of the American Ministry of Health and Human Services. Kennedy, Skeptic vaccine, took steps to Discourage routine immunization In the US, last week Removing all panel members which advises centers for control and prevention of disease on vaccines.
Regencyell’s Stock often creates huge one-day swings. For example, actions jumped approximately 30% 21. March, before they rejected 30% of the next trading day.
Vague treatments, zero income
Despite the wild spike in stock, a little known about the efficiency and commercialization of Regencel treatments for adhd disorders and autistic spectras.
Regencel’s business centers at the ownership traditional formula of Chinese Medicine (TCM) developed in partnership with TCM Practition of Sik-Kee Au using its “Sik-Kee au TCM Theory of Brain.“Sik-Kee au is Father of the Executive Director of Regencel Iat-Gai Au, the company announced in a statement of 2022. years.
The Director General controls 86.24% of the total number of extraordinary actions, in accordance with the facts of facts.
Three liquidly based, orally TCM Formula Candidates You claim to deal with mild, moderate and difficult conditions and contain natural ingredients such as so-called “detoxification plant”, blood circulation plants and digestion plants.
“These TCM formulas form the basis of our candidates for TCM products, which we intend to develop and commercialize for the treatment of ADHD and ASD,” Regencell’s Website Site.
In their The latest annual report was submitted last OctoberRegencell said that he did not create any income, nor did he have submitted any regulatory approvals of his TCM formulas. For fiscal years, June 2024 and 2023, Regencell was created by the total net loss of $ 4.36 million and $ 6.06 million, or at 20f base to 20f.
“We have not created revenue from any candidate for TCM formulas or applied for any regulatory approvals, nor have the possibilities of distribution or experience or any patent patent or any patent applications and may never be profitable,” Read the footer.
Regencell did not answer the CNBC comment request.
Regencyell’s The most recent study of the patient caseFrom 15. November 2023, said that 28 patients gave treatment over a period of three months at another trial for effectively and showed the symptoms of ADHD and ASD, according to the company’s website.
In the earlier case, Regencell said in 2021. Years news release That he treated a dozen patients with suspected or confirmed Cowlid-19 cases, using a modified version of au’s modified ownership cold and flu TCM formula TCM. What is described as an improvement in the weeds to form a joint investment with honor EPIC companies is limited to 2021. September to implement further tests and commercializes the cluster company in ASEAN countries.
Buzz online
Stock attracted a small chat on social media in the last few years. These comments that are given to suggest and enthusiasm of retailer – and skepticism.
One user on the Reddit “R / Shortkuezeeze” page ” He wrote on Monday to regency “trades like a meme coin. He bought a little to see what was happening and it fell 50% right after lol.” Another user told the post three months ago, “” Scalp RGC profits every day. “Stock jumped only 1,360% in May.
On LinkedIn in May, one investor said that “I can’t stop laughing“After reading the company description. Another post from User in the pharmaceutical industryAccording to his profile, Last week, Regencell said Regencell became “Stock for Watching” after his spike in May “No official news or catalysts”. Another LinkedIn User last month commented on Regencell, saying, “China, low quantity and official news, Bizarro.”
On X, one user wrote on Monday post said: “For #Completebullsh__Companioftheyear I name Regencell. “
– CNBC’s Scott Schnipper contributed to reporting.
